Zeposia helps cognitive function

Zeposia helps cognitive functionPublished 09 August Zeposia (ozanimod) can help to stabilise or even improve cognition in people with multiple sclerosis (MS) according to a phase 3 clinical trial. Zeposia is taken orally and works by keeping immune cells within the lymph nodes, preventing them crossing into the brain and
Read More

Zeposia approved for MS in Scotland

Zeposia approved for MS in Scotland Published: 10 February 2021 The Scottish Medicines Consortium (SMC) has approved the drug ozanimod (Zeposia) for patients with active relapsing remitting multiple sclerosis (RRMS).  The SMC has said ozanimod can be prescribed for people who are experiencing relapses or those whose MRI scans show
Read More